2012;141(2)(suppl):e691S-e736S. 9. MacLean S, Mulla S, Akl EA, et al. Patient values and pref- erences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physi- cians evidence-based clinical practice guidelines. Chest. 2012;141(2)(suppl):e1S-e23S. 10. Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of antithrombotic therapy and preven- tion of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guide- lines. Chest. 2012;141(2)(suppl):53S-70S. 11. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke. 2009;40(6):2068-2072. 12. Stroke Risk in Atrial Fibrillation Working Group. Compar- ison of 12 risk strati cation schemes to predict stroke in patients with nonvalvular atrial brillation. Stroke. 2008; 39(6):1901-1910. 13. L vy S, Camm AJ, Saksena S, et al; Working Group on Arrhythmias, Working Group on Cardiac Pacing of the European Society of Cardiology, North American Society of Pacing and Electrophysiology. International consensus on nomenclature and classi cation of atrial brillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the Euro- pean Society of Cardiology and the North American Soci- ety of Pacing and Electrophysiology. Europace. 2003;5(2): 119-122. www.chestpubs.org CHEST / 141 / 2 / FEBRUARY, 2012 SUPPLEMENT e571S 79,884 atrial brillation patients in general practice. J Thromb Haemost. 2011;9(1):39-48. 44. Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial brillation: how well do randomized trials translate into clinical practice? JAMA. 2003;290(20):2685-2692. 45. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial brillation: the AnTicoagulation and Risk factors In Atrial brillation (ATRIA) study. Circulation. 2005;112(12): 1687-1691. 